Trial0

Clinical trial · NCT07332377 · RECRUITING · NA

mHealth Intervention for Pain Self Management

Sponsor: Virginia Commonwealth University

We save this real registry record and notify you if its published status changes. Create an account to add profile details that improve future matching.

Summary

This is a feasibility pilot test of a single-arm intervention to evaluate the beta version of an mHealth app-based behavioral intervention prior to scaling for a randomized controlled trial (RCT). This mHealth intervention is designed to enhance self-efficacy and support pain and symptom self-management among post-treatment cancer survivors.

Interventions

  • Mobile Health (mHealth) Intervention · BEHAVIORAL

    Individuals will use the mHealth app for 1 week. Participants will interact with evidence-based messages and will complete ecological momentary assessments (EMA's) (two times per day) and electronic diaries (e-diaries) daily.

Published eligibility criteria

Verbatim from the registry. Only the site can decide how these apply to a specific patient.

Inclusion Criteria:

* In a post-treatment stage with no evidence of disease (complete remission)
* Diagnosed with cancer in the past three years
* Experiencing cancer/treatment-related pain
* ≥ 18 years of age at the time of first diagnosis
* Cognitively able to actively participate in an online-based study
* Able to read, write, and understand English

Exclusion Criteria:

* Individuals who currently use any medication for psychiatric reasons (including stimulants, and mood stabilizers)
* Patients with major psychotic disorders (bipolar disorder or schizophrenia) and/or substance use disorders.
* Those who are currently pregnant or plan to become pregnant in the next three months

Sites (1)

  • Virginia Commonwealth University, Richmond, Virginia · RECRUITING

Not medical advice. Trial0 is a navigation service, not a medical provider. Nothing here is medical advice or a recommendation to pursue any treatment; eligibility matching is informational, based on published registry criteria, and only the trial site or treating clinician can determine actual eligibility. Decisions belong with the patient and their own doctors. Registry data refreshed at most hourly; last update posted 2026-03-18.